STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+：RFK 小胜，FDA 咨询委员会以微弱多数投票批准未获批肽类的配制 该小组建议允许配制药房生产流行但未经证实的 BPC-157 和 KPV 肽。 STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides statnews.com
